Russia announces free cancer vaccine for citizens by 2025
HQ Team December 18, 2025: Russia recently announced the development of a cancer vaccine, which is expected to be available for distribution free.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team December 18, 2025: Russia recently announced the development of a cancer vaccine, which is expected to be available for distribution free.
Bharti Jayshankar December 17, 2024: The ICOD (Improving Condition in Down Syndrome) project has reported promising findings from its phase 1/2 clinical trial.
HQ Team December 17, 2024: In a study conducted in Churchill, Manitoba—often dubbed the “Polar Bear Capital of the World”—researchers from Dalhousie University.
HQ Team December 16, 2024: The 2023 World Air Quality Report, released by Swiss air quality technology company IQAir, revealed that only seven.
Bharti Jayshankar December 16, 2024: Researchers at the Rajiv Gandhi Biotechnology Centre, Kerala, delving into the molecular mechanisms of tumorigenesis by BRCA1 gene,.
HQ Team December 13, 2024: Novo Nordisk has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP).
HQ Team December 13, 2024: The Institute for Clinical and Economic Review (ICER) has released a new report revealing that five high-expenditure drugs.
Bharti Jayshankar December 13, 2024: AstraZeneca and Merck have announced long-term results from the OlympiA Phase 3 trial, showing that Lynparza (olaparib) significantly.
HQ Team December 12, 2024: Filamon Limited, an Australian biotech company, has announced a significant advancement in dementia treatment with its new drug,.
About one person every second or 42 million people each year are estimated to contract genital herpes infection worldwide, according to the World.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com (opens in a new window)